Radical local therapy offers mortality benefit in very high-risk prostate cancer

Guidelines recommend androgen deprivation therapy (ADT) only for men with very high-risk prostate cancer (PCa), but new findings from a population-based study suggest that radical local treatment can lower mortality in these patients. Researchers examined the proportion of men who received primary radical local therapy — radical prostatectomy or full-dose radiotherapy with or without androgen deprivation therapy — within one year of diagnosis for very high-risk and locally advanced prostate cancer.
Renal & Urology News